TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X906. A total of 4 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $211,000 | +80.3% | 120 | -0.8% | 0.03% | +81.2% |
| Q2 2021 | $117,000 | -83.1% | 121 | -81.3% | 0.02% | -88.1% |
| Q1 2021 | $694,000 | -73.7% | 646 | -65.3% | 0.14% | -65.8% |
| Q3 2020 | $2,643,000 | +43.6% | 1,860 | -18.2% | 0.40% | +7.0% |
| Q2 2020 | $1,840,000 | +355.4% | 2,275 | +127.5% | 0.37% | +119.6% |
| Q1 2020 | $404,000 | – | 1,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,275 | $1,840,000 | 0.37% |
| GROUP ONE TRADING, L.P. | 60,300 | $488,000 | 0.00% |
| SIMPLEX TRADING, LLC | 160 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |